The aim of this study is to determine the risk factors for development of ventilator-associated pneumonia (VAP) and to identify the prognostic factors of VAP among Coronavirus Disease 2019 (CoViD-19) patients. We hypothesized that CoViD-19 serves as a high risk factor for the development of VAP and it affects clinical outcome measures negatively.
Coronavirus Disease 2019 (CoViD-19) caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) became a pandemic affecting thousands of individuals worldwide. A considerable
proportion of CoViD-19 patients require admission to the intensive care unit (ICU), although
limited data are available on their clinical characteristics and course. The results of
retrospective studies indicate older age, presence of comorbidies and secondary infections as
predictors of mortality among this population. Further evaluation regarding ICU clinical
course and predictors of mortality is needed.
The aim of this study is to determine the risk factors for development of VAP and to identify
the prognostic factors of VAP among CoViD-19 patients.
Diagnostic Test: Assessment of ventilator-associated pneumonia criteria
Diagnosis of ventilator-associated pneumonia is based upon the routine daily clinical and laboratory parameters.
Inclusion Criteria:
- Critically ill individuals diagnosed with PCR confirmed CoViD-19 disease
- Started mechanical ventilation for > 48 hours
- Informed consent signed by the patient or authorised representative
Exclusion Criteria:
- Participation in an interventional trial aiming nosocomial infections
- refused informed consent
Semmelweis University
Budapest, Hungary
Investigator: Bence Mogyoródi, MD
Contact: +36208250801
mogyorodi.bence@med.semmelweis-univ.hu